RYVIX | VENAX | RYVIX / VENAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 27 years | 20 years | - |
Gain YTD | -10.314 | 2.628 | -392% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 100000 | 3% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.09M | 10.3B | 0% |
Annual Yield % from dividends | 0.00 | 2.93 | - |
Returns for 1 year | -10.98 | 1.28 | -858% |
Returns for 3 years | 32.78 | 56.94 | 58% |
Returns for 5 years | -1.50 | 47.95 | -3% |
Returns for 10 years | -64.61 | 7.06 | -916% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NVSCX | 31.77 | 0.24 | +0.76% |
Allspring Small Company Growth Admin | |||
JHERX | 18.94 | 0.13 | +0.69% |
JHancock Equity Income C | |||
FTASX | 28.79 | 0.15 | +0.52% |
Fidelity Advisor Asset Manager 70% M | |||
TDFCX | 7.96 | N/A | N/A |
Transamerica Sustainable Equity Inc C | |||
GEBNX | 10.05 | N/A | N/A |
Goldman Sachs ESG Em Mkts Eq Inv |